All of our epidemiology estimates are built upon a foundation of population projections by age, gender, and race/ethnicity (if relevant). Changing demographics and its impact on future population projections is one of the most-overlooked factors in forecasting.
We supplement your internal and proprietary sources by scouring publicly available sources to arrive at the best possible patient population estimates. Sources include published literature, as well as public and private datasets. Our unique ability to derive defendable estimates from seemingly disparate data sets us apart. This helps us paint a fuller picture of the patient journey, and uncovers hidden opportunities and pitfalls in the market.
We offer in-depth market analysis to help pharmaceutical companies understand industry trends, competitive landscape, as well as payer and consumer behavior.